SMAD3 and obesity disorder: Most recently, a comprehensive study highlighted the critical involvement of TGF-β/Smad3 signaling during the process of obesity and demonstrated the beneficial effects of systemic blockade of this signaling from obesity, diabetes, and hepatic steatosis (Yadav et al., 2011).